481 related articles for article (PubMed ID: 37753266)
41. Ultrastructural evidence of microglial heterogeneity in Alzheimer's disease amyloid pathology.
El Hajj H; Savage JC; Bisht K; Parent M; Vallières L; Rivest S; Tremblay MÈ
J Neuroinflammation; 2019 Apr; 16(1):87. PubMed ID: 30992040
[TBL] [Abstract][Full Text] [Related]
42. Cattle Encephalon Glycoside and Ignotin Attenuates Aβ1-42-Mediated Neurotoxicity by Preventing NLRP3 Inflammasome Activation and Modulating Microglial Polarization via TLR4/NF-κB Signaling Pathway.
Gao Y; Li S; Zhang Y; Zhang J; Zhao Y; Chang C; Gao X; Yang G
Neurotox Res; 2022 Dec; 40(6):1802-1811. PubMed ID: 36214996
[TBL] [Abstract][Full Text] [Related]
43. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
[TBL] [Abstract][Full Text] [Related]
44. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.
Tang Y; Le W
Mol Neurobiol; 2016 Mar; 53(2):1181-1194. PubMed ID: 25598354
[TBL] [Abstract][Full Text] [Related]
45. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
46. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
[TBL] [Abstract][Full Text] [Related]
47. MFG-E8 Selectively Inhibited Aβ-Induced Microglial M1 Polarization via NF-κB and PI3K-Akt Pathways.
Shi X; Cai X; Di W; Li J; Xu X; Zhang A; Qi W; Zhou Z; Fang Y
Mol Neurobiol; 2017 Dec; 54(10):7777-7788. PubMed ID: 27844286
[TBL] [Abstract][Full Text] [Related]
48. An early and late peak in microglial activation in Alzheimer's disease trajectory.
Fan Z; Brooks DJ; Okello A; Edison P
Brain; 2017 Mar; 140(3):792-803. PubMed ID: 28122877
[TBL] [Abstract][Full Text] [Related]
49. Dysfunctional microglia and tau pathology in Alzheimer's disease.
Ayyubova G
Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
[TBL] [Abstract][Full Text] [Related]
50. Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
Casaletto KB; Nichols E; Aslanyan V; Simone SM; Rabin JS; La Joie R; Brickman AM; Dams-O'Connor K; Palta P; Kumar RG; George KM; Satizabal CL; Schneider J; Pa J
Brain; 2022 Oct; 145(10):3536-3545. PubMed ID: 35869598
[TBL] [Abstract][Full Text] [Related]
51. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
de Almeida EJR; Ibrahim HJ; Chitolina Schetinger MR; de Andrade CM; Cardoso AM
Neurochem Res; 2022 Nov; 47(11):3221-3240. PubMed ID: 35962936
[TBL] [Abstract][Full Text] [Related]
52. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
53. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
[TBL] [Abstract][Full Text] [Related]
54. Exploring the Significance of Microglial Phenotypes and Morphological Diversity in Neuroinflammation and Neurodegenerative Diseases: From Mechanisms to Potential Therapeutic Targets.
Anwar MM; Pérez-Martínez L; Pedraza-Alva G
Immunol Invest; 2024 Jun; ():1-56. PubMed ID: 38836373
[TBL] [Abstract][Full Text] [Related]
55. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
56. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
Regen F; Hellmann-Regen J; Costantini E; Reale M
Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
[TBL] [Abstract][Full Text] [Related]
57. Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.
Haque ME; Kim IS; Jakaria M; Akther M; Choi DK
Front Cell Neurosci; 2018; 12():258. PubMed ID: 30186116
[TBL] [Abstract][Full Text] [Related]
58. The Role of Non-coding RNAs in Alzheimer's Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers.
Zhang Y; Zhao Y; Ao X; Yu W; Zhang L; Wang Y; Chang W
Front Aging Neurosci; 2021; 13():654978. PubMed ID: 34276336
[TBL] [Abstract][Full Text] [Related]
59. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury.
Wu H; Zheng J; Xu S; Fang Y; Wu Y; Zeng J; Shao A; Shi L; Lu J; Mei S; Wang X; Guo X; Wang Y; Zhao Z; Zhang J
J Neuroinflammation; 2021 Jan; 18(1):2. PubMed ID: 33402181
[TBL] [Abstract][Full Text] [Related]
60. Synergistic photobiomodulation with 808-nm and 1064-nm lasers to reduce the β-amyloid neurotoxicity in the
Zhang R; Zhou T; Samanta S; Luo Z; Li S; Xu H; Qu J
Front Neuroimaging; 2022; 1():903531. PubMed ID: 37555169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
